Skip to main navigation Skip to search Skip to main content

Pain management in people with inflammatory arthritis: British Society for Rheumatology guideline scope

  • Ian C. Scott
  • , Opeyemi Babatunde
  • , Christopher Barker
  • , Rebecca Beesley
  • , Richard Beesley
  • , Hollie Birkinshaw
  • , Mel Brooke
  • , Hema Chaplin
  • , Lara Chapman
  • , Coziana Ciurtin
  • , James Dale
  • , Dervil Dockrell
  • , Emma Dures
  • , Kathyrn Harrison
  • , Meghna Jani
  • , Charlotte Lee
  • , Maura McCarron
  • , Christian D. Mallen
  • , Assie O’Connor
  • , Claire Pidgeon
  • Tamar Pincus, Dee Pratt, Yeliz Prior, Karim Raza, Zoe Rutter-Locher, Seema Sharma, Katie Shaw, Samantha Small, Tilli Smith, Lesley Tiffin, Jordan Tsigarides, Mikalena Xenophontos, Nicholas G. Shenker

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

Pain is a common symptom in people with inflammatory arthritis (IA), which has far-reaching impacts on their lives. Recent electronic health record studies demonstrate that UK-based pain care in people with IA commonly involves the prescribing of long-term opioids and gabapentinoids, despite an absence of trial evidence for their efficacy. Patient surveys suggest that non-pharmacological pain management is underused. A UK-specific guideline on pain management for people with IA is required to resolve this. This scoping document outlines the context and prioritized clinical questions for the first British Society for Rheumatology (BSR) guideline on pain management for people with IA. The guideline aims to provide evidence-based recommendations on how pain can be best managed in people with IA (including its assessment, and pharmacological and non-pharmacological treatments), ensuring that people with IA in the UK are offered evidence-based pain management strategies. The guideline is for healthcare professionals involved in the care of people with IA of all ages and genders, people with IA and their families and carers, NHS managers and healthcare commissioners, and other relevant stakeholders such as patient organizations. It will be developed using the methods outlined in the BSR’s ‘Creating Clinical Guidelines’ protocol.

Original languageEnglish
Article numberrkae128
JournalRheumatology Advances in Practice
Volume8
Issue number4
DOIs
Publication statusPublished - 19 Nov 2024

Keywords

  • analgesic
  • axial spondyloarthritis
  • inflammatory arthritis
  • juvenile idiopathic arthritis
  • non-pharmacological
  • pain
  • pharmacological
  • psoriatic arthritis
  • rheumatoid arthritis

Cite this